Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters








Language
Year range
1.
Indian J Med Sci ; 2009 Oct; 63(10) 461-463
Article in English | IMSEAR | ID: sea-145454

ABSTRACT

Ciprofloxacin is one of the most commonly used antibacterial agents with relatively few side effects. Serious adverse reactions reported with ciprofloxacin are rare with an incidence of 0.6%. Recently we came across two rare adverse effects of ciprofloxacin, viz. toxic epidermal necrolysis and agranulocytosis. To our knowledge, a total of seven cases have been reported in the literature documenting an association between oral ciprofloxacin administration and toxic epidermal necrolysis. One case of granulocytopenia, four of pancytopenia and fifteen of leucopenia worldwide have been reported. With the use of ciprofloxacin becoming more and more widespread, these two rare but fatal complications of ciprofloxacin should be borne in mind.


Subject(s)
Administration, Oral , Adult , Agranulocytosis/chemically induced , Agranulocytosis/drug therapy , Anti-Bacterial Agents/therapeutic use , Anti-Infective Agents/administration & dosage , Anti-Infective Agents/adverse effects , Ciprofloxacin/administration & dosage , Ciprofloxacin/adverse effects , Stevens-Johnson Syndrome/drug therapy , Stevens-Johnson Syndrome/etiology , Female , Granulocyte Colony-Stimulating Factor/administration & dosage , Granulocyte Colony-Stimulating Factor/therapeutic use , Humans , Leukopenia , Neutropenia , Risk Factors , Sepsis/drug therapy , Thienamycins/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL